Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer.

Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham D, Jassem J, Rivera F, Kocákova I, Ruff P, Błasińska-Morawiec M, Smakal M, Canon JL, Rother M, Oliner KS, Tian Y, Xu F, Sidhu R.

Ann Oncol. 2014 Jul;25(7):1346-55. doi: 10.1093/annonc/mdu141. Epub 2014 Apr 8.

PMID:
24718886
[PubMed - in process]
2.

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.

Butts C, Socinski MA, Mitchell PL, Thatcher N, Havel L, Krzakowski M, Nawrocki S, Ciuleanu TE, Bosquée L, Trigo JM, Spira A, Tremblay L, Nyman J, Ramlau R, Wickart-Johansson G, Ellis P, Gladkov O, Pereira JR, Eberhardt WE, Helwig C, Schröder A, Shepherd FA; START trial team.

Lancet Oncol. 2014 Jan;15(1):59-68. doi: 10.1016/S1470-2045(13)70510-2. Epub 2013 Dec 9.

PMID:
24331154
[PubMed - indexed for MEDLINE]
3.

Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer.

Douillard JY, Oliner KS, Siena S, Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham D, Jassem J, Rivera F, Kocákova I, Ruff P, Błasińska-Morawiec M, Šmakal M, Canon JL, Rother M, Williams R, Rong A, Wiezorek J, Sidhu R, Patterson SD.

N Engl J Med. 2013 Sep 12;369(11):1023-34. doi: 10.1056/NEJMoa1305275.

PMID:
24024839
[PubMed - indexed for MEDLINE]
Free Article
4.

Need for objective and reproducible criteria in histopathological assessment of total mesorectal excision specimens: lessons from a national improvement project.

Demetter P, Vandendael T, Sempoux C, Ectors N, Cuvelier CA, Nagy N, Hoorens A, Jouret-Mourin A; PROCARE.

Colorectal Dis. 2013 Nov;15(11):1351-8. doi: 10.1111/codi.12362.

PMID:
23865820
[PubMed - in process]
5.

Randomised, placebo-controlled, double-blind, parallel-group phase III study evaluating aflibercept in patients receiving first-line treatment with gemcitabine for metastatic pancreatic cancer.

Rougier P, Riess H, Manges R, Karasek P, Humblet Y, Barone C, Santoro A, Assadourian S, Hatteville L, Philip PA.

Eur J Cancer. 2013 Aug;49(12):2633-42. doi: 10.1016/j.ejca.2013.04.002. Epub 2013 Apr 30.

PMID:
23642329
[PubMed - indexed for MEDLINE]
6.

Sinusoidal obstruction syndrome (SOS) related to chemotherapy for colorectal liver metastases: factors predictive of severe SOS lesions and protective effect of bevacizumab.

Hubert C, Sempoux C, Humblet Y, van den Eynde M, Zech F, Leclercq I, Gigot JF.

HPB (Oxford). 2013 Jan 18. doi: 10.1111/hpb.12047. [Epub ahead of print]

PMID:
23458554
[PubMed - as supplied by publisher]
7.

Massively parallel tumor multigene sequencing to evaluate response to panitumumab in a randomized phase III study of metastatic colorectal cancer.

Peeters M, Oliner KS, Parker A, Siena S, Van Cutsem E, Huang J, Humblet Y, Van Laethem JL, André T, Wiezorek J, Reese D, Patterson SD.

Clin Cancer Res. 2013 Apr 1;19(7):1902-12. doi: 10.1158/1078-0432.CCR-12-1913. Epub 2013 Jan 16.

PMID:
23325582
[PubMed - indexed for MEDLINE]
Free Article
8.

Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Grothey A, Van Cutsem E, Sobrero A, Siena S, Falcone A, Ychou M, Humblet Y, Bouché O, Mineur L, Barone C, Adenis A, Tabernero J, Yoshino T, Lenz HJ, Goldberg RM, Sargent DJ, Cihon F, Cupit L, Wagner A, Laurent D; CORRECT Study Group.

Lancet. 2013 Jan 26;381(9863):303-12. doi: 10.1016/S0140-6736(12)61900-X. Epub 2012 Nov 22.

PMID:
23177514
[PubMed - indexed for MEDLINE]
9.

Intrapatient cetuximab dose escalation in metastatic colorectal cancer according to the grade of early skin reactions: the randomized EVEREST study.

Van Cutsem E, Tejpar S, Vanbeckevoort D, Peeters M, Humblet Y, Gelderblom H, Vermorken JB, Viret F, Glimelius B, Gallerani E, Hendlisz A, Cats A, Moehler M, Sagaert X, Vlassak S, Schlichting M, Ciardiello F.

J Clin Oncol. 2012 Aug 10;30(23):2861-8. doi: 10.1200/JCO.2011.40.9243. Epub 2012 Jul 2.

PMID:
22753904
[PubMed - indexed for MEDLINE]
10.

A phase II randomized study of combined infusional leucovorin sodium and 5- FU versus the leucovorin calcium followed by 5-FU both in combination with irinotecan or oxaliplatin in patients with metastatic colorectal cancer.

Bleiberg H, Vandebroek A, Deleu I, Vergauwe P, Rezaei Kalantari H, D'Haens G, Paesmans M, Peeters M, Efira A, Humblet Y.

Acta Gastroenterol Belg. 2012 Mar;75(1):14-21.

PMID:
22567742
[PubMed - indexed for MEDLINE]
11.

Risk adjusted benchmarking of abdominoperineal excision for rectal adenocarcinoma in the context of the Belgian PROCARE improvement project.

Penninckx F, Fieuws S, Beirens K, Demetter P, Ceelen W, Kartheuser A, Molle G, Van de Stadt J, Vindevoghel K, Van Eycken E; PROCARE.

Gut. 2013 Jul;62(7):1005-11. doi: 10.1136/gutjnl-2011-301941. Epub 2012 Apr 23.

PMID:
22525885
[PubMed - indexed for MEDLINE]
12.

Exploring limits for data registration in the context of PROCARE, a quality improvement project on rectal cancer.

Vandendael T, Penninckx F, Bertrand C, Ceelen W, Danse E, Demetter P, Haustermans K, Laurent S, Molle G, Vandestadt J, Van Laethem JL, Vindevoghel K, Thijs; PROCARE.

Acta Chir Belg. 2012 Jan;112(1):15-23.

PMID:
22442905
[PubMed - indexed for MEDLINE]
13.

Defunctioning stoma and anastomotic leak rate after total mesorectal excision with coloanal anastomosis in the context of PROCARE.

Beirens K, Penninckx F; PROCARE.

Acta Chir Belg. 2012 Jan;112(1):10-4.

PMID:
22442904
[PubMed - indexed for MEDLINE]
14.

New drugs in medical oncology: new difficulties to distinguish drug-induced side effects from cancer complications: a case-report.

Seront E, Mazzeo F, Mano M, Sterckx M, Humblet Y, Machiels JP, Baurain JF.

Acta Clin Belg. 2011 Nov-Dec;66(6):426-8.

PMID:
22338305
[PubMed - indexed for MEDLINE]
15.

Risk adjusted benchmarking of clinical anastomotic leakage rate after total mesorectal excision in the context of an improvement project.

Penninckx F, Beirens K, Fieuws S, Ceelen W, Demetter P, Haustermans K, Van de Stadt J, Vindevoghel K; PROCARE.

Colorectal Dis. 2012 Jul;14(7):e413-21. doi: 10.1111/j.1463-1318.2012.02977.x.

PMID:
22321047
[PubMed - indexed for MEDLINE]
16.

Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma.

Borbath I, Verbrugghe L, Lai R, Gigot JF, Humblet Y, Piessevaux H, Sempoux C.

Eur J Cancer. 2012 May;48(7):990-6. doi: 10.1016/j.ejca.2011.11.006. Epub 2011 Dec 1.

PMID:
22137164
[PubMed - indexed for MEDLINE]
17.

A phase I clinical and pharmacological study evaluating vinflunine in combination with doxorubicin as first line treatment in metastatic breast cancer.

Zaman K, Durando X, Baurain JF, Humblet Y, Mazzeo F, Bostnavaron M, Meheust N, Monnoyer-Favrel S, Machiels JP, Bauer J.

Breast Cancer Res Treat. 2011 Jun;127(3):689-96. doi: 10.1007/s10549-011-1446-x. Epub 2011 Mar 26.

PMID:
21442199
[PubMed - indexed for MEDLINE]
18.

Randomized, phase III trial of panitumumab with infusional fluorouracil, leucovorin, and oxaliplatin (FOLFOX4) versus FOLFOX4 alone as first-line treatment in patients with previously untreated metastatic colorectal cancer: the PRIME study.

Douillard JY, Siena S, Cassidy J, Tabernero J, Burkes R, Barugel M, Humblet Y, Bodoky G, Cunningham D, Jassem J, Rivera F, Kocákova I, Ruff P, Błasińska-Morawiec M, Šmakal M, Canon JL, Rother M, Oliner KS, Wolf M, Gansert J.

J Clin Oncol. 2010 Nov 1;28(31):4697-705. doi: 10.1200/JCO.2009.27.4860. Epub 2010 Oct 4.

PMID:
20921465
[PubMed - indexed for MEDLINE]
19.

Vascular reconstruction during pancreatoduodenectomy for ductal adenocarcinoma of the pancreas improves resectability but does not achieve cure.

Ouaissi M, Hubert C, Verhelst R, Astarci P, Sempoux C, Jouret-Mourin A, Loundou A, Gigot JF; Multidisciplary HPB Group of Center of Cancer.

World J Surg. 2010 Nov;34(11):2648-61. doi: 10.1007/s00268-010-0699-6.

PMID:
20607257
[PubMed - indexed for MEDLINE]
20.

Successful long-term management of a patient with late-stage metastatic colorectal cancer treated with panitumumab.

Seront E, Marot L, Coche E, Gala JL, Sempoux C, Humblet Y.

Cancer Treat Rev. 2010 Feb;36 Suppl 1:S11-4. doi: 10.1016/S0305-7372(10)70002-5.

PMID:
20189054
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk